glp-1 obesity drug news october 21 2025 Drugmakers are only months into introducing pills and navigating huge changes in how patients pay for weight-loss drugs., Even so, they’re already outlining their visions for the future of Weight-loss drugs such as Ozempic

The GLP-1 Drug Market's growth appears robust, with a projected valuation increase from 10.77 USD Billion in 2024 to 42.0 USD Billion by 2035

Who Are GLP-1 Agonist Drugs For

Check if your Semaglutide or Tirzepatide is covered by insurance

Lacey Anderson said the first oral GLP-1 medication for weight loss, a pill version of Wegovy, received approval from the Food and Drug Administration in December 2025

Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease

Similarly, the evaluation of gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which occur frequently with GLP-1RAs (42) and have a major influence on the adherence to such treatment over time, have often been assessed in clinical trials solely via participant self-report, which is known to be unrelaible (eg, symptoms may not be volunteered due to embarrassment or poor recall) (43, 44)